BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M Turnover 16.91%
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$128M
AUM Growth
-$605K
Cap. Flow
-$4.31M
Cap. Flow %
-3.36%
Top 10 Hldgs %
30.46%
Holding
151
New
9
Increased
24
Reduced
61
Closed
14
Avg Time Held Equity + Options
2.6 years
Top 10 Avg Time Held Equity + Options
1.9 years
Top 20 Avg Time Held Equity + Options
2.2 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
1.9 years
Top 20 Avg Time Held Equity only
2.2 years

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$960K
2
MDT icon
Medtronic
MDT
+$955K
3
DIS icon
Walt Disney
DIS
+$627K
4
CORR
CorEnergy Infrastructure Trust, Inc.
CORR
+$603K
5
JNJ icon
Johnson & Johnson
JNJ
+$573K

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$1.23M
2
MRK icon
Merck
MRK
+$1.04M
3
GM icon
General Motors
GM
+$1.02M
4
REM icon
iShares Mortgage Real Estate ETF
REM
+$990K
5
ABBV icon
AbbVie
ABBV
+$982K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.53%
2 Healthcare 15.93%
3 Real Estate 15.05%
4 Financials 12.27%
5 Technology 12.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
OHI icon
51
Omega Healthcare
OHI
$13.7B
$647K 0.5%
23,475
-1,500
-6% -$43.3K
2016 Q3
5 quarters
DEM icon
52
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.14B
$644K 0.5%
14,199
+400
+3% +$17.5K
2014 Q1
15 quarters
GOOG icon
53
Alphabet (Google) Class C
GOOG
$4.2T
$637K 0.5%
12,180
+180
+2% +$9.16K
2017 Q1
3 quarters
GALT icon
54
Galectin Therapeutics
GALT
$367M
$619K 0.48%
185,200
-9,000
-5% -$22.8K
2013 Q2
18 quarters
DOC icon
55
Healthpeak Properties
DOC
$12.9B
$613K 0.48%
23,500
-5,250
-18% -$139K
2013 Q2
18 quarters
AMGN icon
56
Amgen
AMGN
$230B
$609K 0.48%
3,500
– –
2015 Q4
8 quarters
META icon
57
Meta Platforms (Facebook)
META
$1.88T
$609K 0.48%
3,452
-98
-3% -$17.3K
2013 Q3
17 quarters
JNJ icon
58
Johnson & Johnson
JNJ
$612B
$575K 0.45%
+4,113
New +$573K
2017 Q4
0 quarters
MET.PRA icon
59
MetLife Inc Floating Rate Series A
MET.PRA
$505M
$574K 0.45%
23,100
– –
2013 Q2
18 quarters
SAFE icon
60
Safehold
SAFE
$818M
$571K 0.45%
10,385
-103
-1% -$5.81K
2013 Q2
18 quarters
KW icon
61
DELISTED
Kennedy-Wilson Holdings
KW
$564K 0.44%
32,500
– –
2013 Q2
18 quarters
JCI icon
62
Johnson Controls International
JCI
$92.3B
$549K 0.43%
14,400
-1,200
-8% -$46.9K
2017 Q2
2 quarters
CEMI
63
DELISTED
Chembio diagnostics, Inc.
CEMI
$545K 0.43%
66,417
+33,517
+102% +$227K
2017 Q2
2 quarters
CTSH icon
64
Cognizant
CTSH
$28.1B
$536K 0.42%
7,550
-100
-1% -$7.31K
2017 Q2
2 quarters
COP icon
65
ConocoPhillips
COP
$171B
$530K 0.41%
9,650
-1,400
-13% -$72K
2013 Q2
18 quarters
AGIG icon
66
Abundia Global Impact Group
AGIG
$37.6M
$514K 0.4%
12,472
-84
-0.7% -$4.12K
2013 Q2
18 quarters
RGLD icon
67
Royal Gold
RGLD
$19.1B
$509K 0.4%
6,200
– –
2013 Q4
16 quarters
ROIC icon
68
DELISTED
Retail Opportunity Investments Corp.
ROIC
$479K 0.37%
24,000
– –
2013 Q2
18 quarters
MS.PRA icon
69
Morgan Stanley Series A Preferred Stock
MS.PRA
$757M
$466K 0.36%
20,605
– –
2013 Q2
18 quarters
RDI icon
70
Reading International Class A
RDI
$40.3M
$461K 0.36%
27,600
– –
2013 Q2
18 quarters
BRK.B icon
71
Berkshire Hathaway Class B
BRK.B
$1.13T
$456K 0.36%
2,300
– –
2017 Q3
1 quarter
GM.WS.B icon
72
CALL
DELISTED
General Motors Company
GM.WS.B
$453K 0.35%
19,346
-1,500
-7% -$38.3K
2015 Q3
9 quarters
SNY icon
73
Sanofi
SNY
$95.3B
$451K 0.35%
10,500
-1,100
-9% -$50.7K
2015 Q1
11 quarters
CCEC icon
74
Capital Clean Energy Carriers
CCEC
$1.24B
$444K 0.35%
18,897
-929
-5% -$21.8K
2013 Q2
18 quarters
ALLY icon
75
Ally Financial
ALLY
$11.2B
$437K 0.34%
15,000
– –
2015 Q3
9 quarters
1 2
3
4 5

Similar funds

OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Benchmark Capital Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Benchmark Capital Advisors held 151 positions worth $128M, down 0.47% from $129M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Benchmark Capital Advisors withdrew a net $4.31M in Q4 2017, closing 14 positions and reducing 61 holdings. Its most notable exit was Procter & Gamble, an estimated $1.23M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Benchmark Capital Advisors opened a new position in Intel worth $1.02M.

  • Benchmark Capital Advisors's largest Q4 2017 buy was Intel: 22,000 shares worth $1.02M.
  • Benchmark Capital Advisors added most to Walt Disney in Q4 2017, an estimated $627K increase.
  • Benchmark Capital Advisors's biggest Q4 2017 reduction was General Motors, cutting an estimated $1.02M.
  • Benchmark Capital Advisors fully exited Procter & Gamble in Q4 2017, selling an estimated $1.23M.
  • Benchmark Capital Advisors's ten largest holdings make up 30% of its $128M portfolio in Q4 2017.
  • Benchmark Capital Advisors opened 9 new positions and closed 14 in Q4 2017.
  • Benchmark Capital Advisors's portfolio value fell 0.47% quarter-over-quarter to $128M.

Based on Benchmark Capital Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.